A year after Baby KJ became the first person to receive a personalized CRISPR base-editing therapy for a lethal genetic disorder, he is thriving and has avoided a liver transplant. His case, enabled ...

It took years and major changes in how gene therapies are delivered for the field to recover. And now, 27 years after ...

Diabetes mellitus affects more than 500 million people worldwide, and both Type 1 (T1D) and Type 2 (T2D) forms converge on a common endpoint: the loss or ...

IDT played a pivotal role in manufacturing the personalized gene editing therapy given to baby KJ Muldoon to treat his rare ...

As more products reach the market, therapy developers partner with researchers and regulators to deliver N-of-1 treatments to patients.

Creating standardized building blocks, including gene editing proteins, guide RNAs, donor templates, and delivery vehicles, ...

How do our genes determine our appearance and our susceptibility to disease? This question is central to biomedical research, ...

The ethics of using safe gene therapies to improve the health and cognition of Down syndrome children and adults.

Aging research has entered a transformative era with the advent of genome editing technologies, particularly CRISPR-Cas9, which enable precise and efficient ...

In late April 2026, analysts highlighted expectations for higher year-over-year earnings and revenue at CRISPR Therapeutics ahead of its March-quarter report, alongside strong launch metrics for ...

A CRISPR Therapy Just Cured A Disease From Inside The Body For The First Time. The Gene-Editing Era Officially Started Monday ...